Published in J Leukoc Biol on July 01, 1999
Immunobiology of the TAM receptors. Nat Rev Immunol (2008) 4.26
Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J Exp Med (2001) 3.55
Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol (2004) 2.43
Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection. J Exp Med (2009) 1.70
Adaptive immune responses mediated by natural killer cells. Immunol Rev (2010) 1.48
Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. J Exp Med (2003) 1.37
A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells. J Exp Med (2005) 1.35
Ly49H signaling through DAP10 is essential for optimal natural killer cell responses to mouse cytomegalovirus infection. J Exp Med (2009) 1.16
Turning on natural killer cells. J Exp Med (2000) 1.07
Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome. Genes Immun (2008) 1.00
Ly49 receptors: innate and adaptive immune paradigms. Front Immunol (2014) 0.91
TLR-mediated signaling pathways circumvent the requirement for DAP12 in mast cells for the induction of inflammatory mediator release. Eur J Immunol (2010) 0.90
Viral infection transiently reverses activation receptor-mediated NK cell hyporesponsiveness in an MHC class I-independent mechanism. Eur J Immunol (2013) 0.80
Acquisition of activation receptor ligand by trogocytosis renders NK cells hyporesponsive. J Immunol (2015) 0.77
Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science (1992) 5.94
Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med (1981) 5.76
Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med (1993) 4.94
Natural killer cells: their roles in defenses against disease. Science (1981) 4.59
Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. Science (1994) 3.46
Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature (1994) 3.31
Natural killer cells: characteristics and regulation of activity. Immunol Rev (1979) 3.14
Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects. J Immunol (1984) 3.07
Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies. J Immunol (1981) 3.05
Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity. Nature (1979) 2.94
Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP. Proc Natl Acad Sci U S A (2000) 2.80
Lymphokine-activated killer cells. Analysis of progenitors and effectors. J Exp Med (1986) 2.70
Heterogeneity of natural killer cells. Annu Rev Immunol (1984) 2.59
Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol (1995) 2.52
Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc Natl Acad Sci U S A (1995) 2.52
Lepromin-induced suppressor cells in patients with leprosy. J Immunol (1979) 2.45
Efficacy of physical conditioning exercise in patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum (1989) 2.22
Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc Natl Acad Sci U S A (1995) 2.19
DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase. J Biol Chem (1998) 2.10
Cardiovascular responses in black and white males during exercise. J Appl Physiol (1985) (1993) 2.06
Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes. J Immunol (1986) 2.05
Delineation of a human T cell subset responsible for lepromin-induced suppression in leprosy patients. J Immunol (1980) 2.02
Cytotoxic reactivity of human lymphocytes cultured in vitro. J Immunol (1977) 1.88
Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes. Proc Natl Acad Sci U S A (1994) 1.84
Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12. J Exp Med (1995) 1.78
Acute respiratory distress during caesarean section under spinal anaesthesia. A probable case of anaphylactoid reaction to Syntocinon. Anaesthesia (1994) 1.74
Mechanism of cytotoxicity by natural killer (NK) cells. Annu Rev Immunol (1986) 1.72
Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J Leukoc Biol (1996) 1.70
Staphylococcus aureus microcapsule expression attenuates bacterial virulence in a rat model of experimental endocarditis. J Infect Dis (1992) 1.64
Mutation of Tec family kinases alters T helper cell differentiation. Nat Immunol (2001) 1.63
Relationship of head circumference to measures of school performance. Clin Pediatr (Phila) (1990) 1.62
Expression of antigen-specific, major histocompatibility complex-restricted receptors by cortical and medullary thymocytes in situ. Cell (1985) 1.57
In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4+ T cells. Eur J Immunol (2000) 1.57
Activation of human peripheral blood T lymphocytes by pharmacological induction of protein-tyrosine phosphorylation. Proc Natl Acad Sci U S A (1992) 1.55
Elevated hemidiaphragm after cardiac operations: incidence, prognosis, and relationship to the use of topical ice slush. Ann Thorac Surg (1989) 1.53
Identification of RANTES receptors on human monocytic cells: competition for binding and desensitization by homologous chemotactic cytokines. J Exp Med (1993) 1.53
The nucleotide sequence of the B gene of bacteriophage Mu. Nucleic Acids Res (1984) 1.51
Natural killer activity in the rat. II. Analysis of surface antigens on LGL by flow cytometry. J Immunol (1981) 1.51
Epithelial heterogeneity in the murine thymus: fucose-specific lectins bind medullary epithelial cells. J Immunol (1985) 1.49
One-signal requirement for interferon-gamma production by human large granular lymphocytes. J Immunol (1987) 1.49
Characterization of the family of dimers associated with Fc receptors (Fc epsilon RI and Fc gamma RIII). J Immunol (1991) 1.48
Clinical and clinicopathologic response of canine bone tumor patients to treatment with samarium-153-EDTMP. J Nucl Med (1990) 1.47
Human cellular src gene: nucleotide sequence and derived amino acid sequence of the region coding for the carboxy-terminal two-thirds of pp60c-src. Mol Cell Biol (1985) 1.46
Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver. J Exp Med (1984) 1.41
Tec family kinases modulate thresholds for thymocyte development and selection. J Exp Med (2000) 1.41
DNA sequence encoding the amino-terminal region of the human c-src protein: implications of sequence divergence among src-type kinase oncogenes. Mol Cell Biol (1987) 1.41
Production of interleukin 1 activity by normal human peripheral blood B lymphocytes. J Immunol (1985) 1.40
Mediation of mouse natural cytotoxic activity by tumour necrosis factor. Nature (1986) 1.39
Engagement of the natural killer cell IgG Fc receptor results in tyrosine phosphorylation of the zeta chain. Proc Natl Acad Sci U S A (1991) 1.39
The Ly-49D receptor activates murine natural killer cells. J Exp Med (1996) 1.39
Isolation of human and rat natural killer cells. J Immunol Methods (1982) 1.39
Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells. J Immunol (1986) 1.37
Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells. J Immunol (1999) 1.37
Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies. Cancer Res (1989) 1.37
Specificity of natural cytotoxic reactivity of normal human lymphocytes against a myeloid leukemia cell line. J Natl Cancer Inst (1977) 1.36
Cloning and functional characteristics of murine large granular lymphocyte-1: a member of the Ly-49 gene family (Ly-49G2) J Exp Med (1995) 1.35
Analysis by a single cell cytotoxicity assay of natural killer (NK) cells frequencies among human large granular lymphocytes and of the effects of interferon on their activity. J Immunol (1982) 1.34
IL-2 regulation of tyrosine kinase activity is mediated through the p70-75 beta-subunit of the IL-2 receptor. J Immunol (1989) 1.33
Cytotoxicity by cultured human lymphocytes: characteristics of effector cells and specificity of cytotoxicity. J Immunol (1979) 1.32
Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2. Blood (2000) 1.31
Selective depletion of human natural killer cells on monolayers of target cells. J Immunol (1980) 1.29
Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity. J Exp Med (1999) 1.27
The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: inhibition of AP1 binding and activation of a silencer element. Mol Cell Biol (1996) 1.26
The ever-expanding Ly49 gene family: repertoire and signaling. Immunol Rev (2001) 1.26
Identification of bidirectional promoters in the human KIR genes. Genes Immun (2007) 1.25
A species of human alpha interferon that lacks the ability to boost human natural killer activity. Proc Natl Acad Sci U S A (1984) 1.23
Interleukin 2 induction of pore-forming protein gene expression in human peripheral blood CD8+ T cells. J Exp Med (1990) 1.22
Isolation and structural mapping of a human c-src gene homologous to the transforming gene (v-src) of Rous sarcoma virus. J Virol (1985) 1.20
Expression and role of p75 interleukin 2 receptor on human monocytes. J Exp Med (1990) 1.19
A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding. Endocr Relat Cancer (2005) 1.18
Human large granular lymphocytes are potent producers of interleukin-1. Nature (1984) 1.18
IL-8 gene expression and production in human peripheral blood lymphocyte subsets. J Immunol (1991) 1.18
The value of the physical examination in the diagnosis of anemia. Correlation of the physical findings and the hemoglobin concentration. Arch Intern Med (1988) 1.18
A cyclophilin-related protein involved in the function of natural killer cells. Proc Natl Acad Sci U S A (1993) 1.17
Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta. J Immunol (1991) 1.17
Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies. J Immunol (1987) 1.17
A role for protein tyrosine kinase activity in natural cytotoxicity as well as antibody-dependent cellular cytotoxicity. Effects of herbimycin A. J Immunol (1992) 1.17
Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J Immunol (1985) 1.17
The Ly-49 family: regulation of cytotoxicity and cytokine production in murine CD3+ cells. J Immunol (1998) 1.16
Class I MHC-binding characteristics of the 129/J Ly49 repertoire. J Immunol (2001) 1.15
Transformation of owl monkey T cells in vitro with Herpesvirus saimiri. Proc Natl Acad Sci U S A (1984) 1.14
Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7. J Exp Med (1995) 1.14
Analysis of T cell receptors in highly purified rat and human large granular lymphocytes (LGL): lack of functional 1.3 kb beta-chain mRNA. J Immunol (1986) 1.14
Effects of metabolic inhibitors on spontaneous and interferon-boosted human natural killer cell activity. J Immunol (1980) 1.12
Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes. Int J Cancer (1983) 1.12